Key points are not available for this paper at this time.
The proteins eIF-4E BP1 and p70 S6 kinase each undergo an insulin/mitogen-stimulated phosphorylation in situ that is partially inhibited by rapamycin. Previous work has established that the protein known as mTOR/RAFT-1/FRAP is the target through which the rapamycin·FKBP12 complex acts to dephosphorylate/deactivate the p70 S6 kinase; thus, some mTOR mutants that have lost the ability to bind to the rapamycin·FKBP12 complex in vitro can protect the p70 S6 kinase against rapamycin-induced dephosphorylation/deactivationin situ. We show herein that such mTOR mutants also protect eIF-4E BP1 against rapamycin-induced dephosphorylation, and for both p70 S6 kinase and eIF-4E BP1, such protection that the mTOR an mutants p70 S6 kinase to by in situ to protect eIF-4E BP1 rapamycin-induced We that mTOR is an eIF-4E BP1 as as the p70 S6 kinase; mTOR in The proteins eIF-4E BP1 and p70 S6 kinase each undergo an insulin/mitogen-stimulated phosphorylation in situ that is partially inhibited by rapamycin. Previous work has established that the protein known as mTOR/RAFT-1/FRAP is the target through which the rapamycin·FKBP12 complex acts to dephosphorylate/deactivate the p70 S6 kinase; thus, some mTOR mutants that have lost the ability to bind to the rapamycin·FKBP12 complex in vitro can protect the p70 S6 kinase against rapamycin-induced dephosphorylation/deactivationin situ. We show herein that such mTOR mutants also protect eIF-4E BP1 against rapamycin-induced dephosphorylation, and for both p70 S6 kinase and eIF-4E BP1, such protection that the mTOR an mutants p70 S6 kinase to by in situ to protect eIF-4E BP1 rapamycin-induced We that mTOR is an eIF-4E BP1 as as the p70 S6 kinase; mTOR in is an is the protein to to the by the and both in situ as through the through The complex by protein The rapamycin·FKBP12 complex and in situ the p70 S6 kinase an for the to in some in and the target rapamycin·FKBP12 in situ to the the p70 S6 kinase is the protein known as proteins in is The proteins the that to rapamycin-induced as The and proteins and mTOR that protein kinase to the protein kinase and the and and to the The complex to and the that in situ in The as the target for p70 S6 kinase has established by the work that p70 which the ability to bind to the rapamycin-induced that the BP1 is to the and eIF-4E to The eIF-4E the and the protein the the phosphorylation eIF-4E BP1 in the can phosphorylation eIF-4E BP1 is inhibited by as is for the is that the in by eIF-4E BP1 phosphorylation The the eIF-4E BP1 in situ is eIF-4E BP1 is by protein kinase in the eIF-4E BP1 eIF-4E BP1 is for the p70 S6 kinase in the p70 S6 kinase and the phosphorylation eIF-4E BP1 in to We is the that eIF-4E BP1 and to eIF-4E BP1 through the p70 We as mTOR the ability to the phosphorylation eIF-4E in p70 to eIF-4E BP1 phosphorylation by rapamycin. We that the phosphorylation both eIF-4E BP1 and the p70 S6 kinase; p70 is eIF-4E BP1 is in and and The against and against to S6 kinase and by and and that in the kinase and and and and and to The to to the kinase and the to the kinase The to for which the an to and in to in the mTOR by the the and the mTOR the to The mTOR also as to the mTOR by the by the for each as for for for for the and by the by BP1 by as and the and The eIF-4E BP1 by and the p70 S6 kinase and the in the an and the the and as and and and as the proteins in by the and to to the the to that and and in and the for the to The to protein and the and The by and for and by The proteins by and and p70 S6 S6 kinase in by S6 as The The S6 kinase by the protein kinase and S6 The S6 protein kinase protein kinase and The for The S6 kinase by and The by in by The kinase by by and the as by the mTOR to and proteins in the and the mTOR as in proteins and the mTOR and for The by each to and to the mTOR The the proteins for The and the proteins by to and The proteins by proteins by the in that and the to by to that the proteins the by to and to mTOR an and and the the and by the The the for to the vitro phosphorylation that the vitro mTOR by in the mTOR to in to to the kinase The mTOR which is to mTOR to the in which to the which to mTOR vitro that the mTOR is and is that the an ability to phosphorylation in an to an which kinase and in mTOR in to and mTOR each for as and the to to mTOR The and to in as and to ability to in in vitro to is is mTOR to in vitro in Previous work has the in and and that in can the mTOR to We that mTOR by in the mTOR to in mTOR mTOR to The also to the complex to an to as the mTOR to is to the mTOR in situ by ability to the p70 kinase in situ. The kinase an S6 in in is inhibited by to p70 is p70 p70 in vitro as the p70 that p70 the mTOR the by The mTOR which is in to is also to protect p70 against to and protection against p70 kinase The ability mTOR to protect p70 mTOR which mTOR in vitro also the ability mTOR to p70 the mTOR which is in vitro is and is to bind in vitro protection for p70 against in situ. the in to mTOR also an mTOR for p70 S6 p70 S6 kinase protect eIF-4E BP1 rapamycin-induced BP1 and p70 the by the to The and the to and by S6 The kinase by and to The to The for and and the proteins by p70 kinase by mTOR to in and as as in each to S6 kinase each is the kinase The each to and and to p70 and the mTOR eIF-4E in as to that for to the eIF-4E BP1 to phosphorylation the eIF-4E BP1 in the the eIF-4E BP1 to the p70 to eIF-4E BP1 mTOR the rapamycin-induced in eIF-4E BP1 and mTOR and and mTOR the ability mTOR to protect against is by the mTOR through an eIF-4E BP1 phosphorylation by and the phosphorylation eIF-4E BP1 by and rapamycin. BP1 the as and and and the to and mTOR rapamycin-induced eIF-4E BP1 and the each the each and and in the for for and for and the to the by and the proteins by The for and for The proteins in the by to and The each and to and to the mTOR mTOR eIF-4E BP1 rapamycin-induced an mTOR kinase to in BP1 and as in each to as to to the by for and the for and and the proteins by and by The to and to the mTOR in p70 S6 kinase and in to and mTOR mutants to both mTOR by to the by the p70 kinase can by p70 that have to that is to situ by rapamycin. p70 the p70 in p70 that kinase that is that p70 both in the is to by p70 can protect eIF-4E BP1 rapamycin-induced dephosphorylation, p70 the The eIF-4E BP1 and the the p70 and rapamycin. the p70 p70 S6 as as in the eIF-4E the the inhibited by rapamycin. the in the in the eIF-4E that p70 is eIF-4E BP1 phosphorylation in the the ability mTOR to in vitro to phosphorylation can the ability mTOR to bind in in and the mTOR in vitro that the mTOR which is to bind in partially protect the p70 S6 kinase by the p70 S6 and protection an mTOR to eIF-4E show that the rapamycin-induced eIF-4E BP1, that can also by mTOR mTOR as p70 S6 the the phosphorylation eIF-4E BP1 is that eIF-4E BP1 p70 is to rapamycin-induced eIF-4E BP1, that the rapamycin-induced in phosphorylation eIF-4E is the the mTOR is eIF-4E BP1 as as the p70 S6 p70 is eIF-4E is to that the phosphorylation both p70 and eIF-4E BP1, each p70 eIF-4E in and that the ability mTOR to protect both p70 and eIF-4E BP1 rapamycin-induced in situ is by mTOR that mTOR that the mTOR and which also the in vitro mTOR mTOR protection p70 that the rapamycin·FKBP12 complex in vitro mTOR is that an mTOR is to the phosphorylation the p70 kinase and eIF-4E BP1 in and the rapamycin·FKBP12 to the by which mTOR to the phosphorylation p70 and eIF-4E have ability mTOR mTOR to to p70 S6 kinase eIF-4E BP1 to mTOR p70 and eIF-4E BP1 the that mTOR the phosphorylation proteins can is that mTOR acts BP1 by protein protein that p70 and eIF-4E that mTOR BP1 is the the that p70 in situ phosphorylation that can inhibited by that is by rapamycin. mTOR to the that p70 to the an eIF-4E by the mTOR The the kinase that mTOR is have kinase in in is kinase is an the mTOR an BP1, the mTOR the mTOR p70 to the in that to rapamycin-induced the mTOR to the in the also that the to to the the We that mTOR mTOR p70 rapamycin-induced The mTOR in p70 in p70 is mTOR by the in that mTOR some protection p70 by the protection is that by mTOR which p70 the mTOR the by to p70 to to the p70 in the mTOR to that in the for the mTOR is is that mTOR is to in ability to to the p70 S6 is to the by mTOR to to mTOR mTOR for and is to mTOR and as mTOR the mTOR is also p70 S6 kinase and an eIF-4E BP1 phosphorylation the mTOR the to for the the mTOR to p70 and eIF-4E The proteins that and the and that p70 and eIF-4E BP1 the the in and that and mTOR can the phosphorylation in vitro have is an is the protein to to the by the and both in situ as through the through The complex by protein The rapamycin·FKBP12 complex and in situ the p70 S6 kinase an for the to in some in and the target rapamycin·FKBP12 in situ to the the p70 S6 kinase is the protein known as The proteins in is The proteins the that to rapamycin-induced as The and proteins and mTOR that protein kinase to the protein kinase and the and and to the The complex to and the that in situ in The as the target for p70 S6 kinase has established by the work that p70 which the ability to bind to the rapamycin-induced that the BP1 is to the and eIF-4E to The eIF-4E the and the protein the the phosphorylation eIF-4E BP1 in the can phosphorylation eIF-4E BP1 is inhibited by as is for the is that the in by eIF-4E BP1 phosphorylation The the eIF-4E BP1 in situ is eIF-4E BP1 is by protein kinase in the eIF-4E BP1 eIF-4E BP1 is for the p70 S6 kinase in the p70 S6 kinase and the phosphorylation eIF-4E BP1 in to We is the that eIF-4E BP1 and to eIF-4E BP1 through the p70 We as mTOR the ability to the phosphorylation eIF-4E in p70 to eIF-4E BP1 phosphorylation by rapamycin. We that the phosphorylation both eIF-4E BP1 and the p70 S6 kinase; p70 is eIF-4E BP1 is in and and The against and against to S6 kinase and by and and that in the kinase and and and and and to The to to the kinase and the to the kinase The to for which the an to and in to in the mTOR by the the and the mTOR the to The mTOR also as to the mTOR by the by the for each as for for for for the and by the by BP1 by as and the and The eIF-4E BP1 by and the p70 S6 kinase and the in the an and the the and as and and and as the proteins in by the and to to the the to that and and in and the for the to The to protein and the and The by and for and by The proteins by and and p70 S6 S6 kinase in by S6 as The The S6 kinase by the protein kinase and S6 The S6 protein kinase protein kinase and The for The S6 kinase by and The by in by The kinase by by and the as by the mTOR to and proteins in the and the mTOR as in proteins and the mTOR and for The by each to and to the mTOR The the proteins for The and the proteins by to and The proteins by proteins by the in that and the to by to that the proteins the by to and to and and The against and against to S6 kinase and by and and that in the kinase and and and and and to The to to the kinase and the to the kinase The to for which the an to and in to in the mTOR by the the and the mTOR the to The mTOR also as to the mTOR by the by the for each as for for for for the and by the by BP1 by as and the and The eIF-4E BP1 by and the p70 S6 kinase and the in the an and the the and as and and and as the proteins in by the and to to the the to that and and in and the for the to The to protein and the and The by and for and by The proteins by and and p70 S6 S6 kinase in by S6 as The The S6 kinase by the protein kinase and S6 The S6 protein kinase protein kinase and The for The S6 kinase by and The by in by The kinase by by and the as by the mTOR to and proteins in the and the mTOR as in proteins and the mTOR and for The by each to and to the mTOR The the proteins for The and the proteins by to and The proteins by proteins by the in that and the to by to that the proteins the by to and to and by and and that in the kinase and and and and and to The to to the kinase and the to the kinase The to for which the an to and in to in the mTOR by the the and the mTOR the to The mTOR also as to the mTOR by the by the for each as for for for for the and by the by BP1 by as and the and The eIF-4E BP1 by and the p70 S6 kinase and the in the an and the the and as and and and as the proteins in by the and to to the the to that and and in and the for the to The to protein and the and The by and for and by The proteins by and and p70 S6 S6 kinase in by S6 as The The S6 kinase by the protein kinase and S6 The S6 protein kinase protein kinase and The for The S6 kinase by and The by in by The kinase by by and the as by the mTOR to and proteins in the and the mTOR as in proteins and the mTOR and for The by each to and to the mTOR The the proteins for The and the proteins by to and The proteins by proteins by the in that and the to by to that the proteins the by to and to and by and and that in the kinase and and and and and to The to to the kinase and the to the kinase The to for which the an to and in to in the mTOR by the the and the mTOR the to The mTOR also as to the mTOR by the by the for each as for for for for the and by the by BP1 by as and the and The eIF-4E BP1 by and the p70 S6 kinase and the in the an and the the and as by and and that in the kinase and and and and and to The to to the kinase and the to the kinase The to for which the an to and in to in the mTOR by the the and the mTOR the to The mTOR also as to the mTOR by the by the for each as for for for for the and by the by BP1 by as and the and The eIF-4E BP1 by and The the p70 S6 kinase and the in the an and the the and as and and and as the proteins in by the and to to the the to that and and and as the proteins in by the and to to the the to that and and in and the for the to The to protein and the and The by and for and by The proteins by and in and the for the to The to protein and the and The by and for and by The proteins by and and p70 S6 S6 kinase in by S6 as The The S6 kinase by the protein kinase and S6 The S6 protein kinase protein kinase and The for The S6 kinase by and The by in by The kinase by by and the as by the p70 S6 kinase in by S6 as The The S6 kinase by the protein kinase and S6 The S6 protein kinase protein kinase and The for The S6 kinase by and The by in by The kinase by by and the as by the mTOR to and proteins in the and the mTOR as in proteins and the mTOR and for The by each to and to the mTOR The the proteins for The and the proteins by to and The proteins by proteins by the in that and the to by to that the proteins the by to and to and proteins in the and the mTOR as in proteins and the mTOR and for The by each to and to the mTOR The the proteins for The and the proteins by to and The proteins by proteins by the in that and the to by to that the proteins the by to and to mTOR an and and the the and by the The the for to the vitro phosphorylation that the vitro mTOR by in the mTOR to in to to the kinase The mTOR which is to mTOR to the in which to the which to mTOR vitro that the mTOR is and is that the an ability to phosphorylation in an to an which kinase ability to in in vitro to is is mTOR to in vitro in Previous work has the in and and that in can the mTOR to We that mTOR by in the mTOR to in mTOR mTOR to The also to the complex to an to as the mTOR to is to the mTOR in situ by ability to the p70 kinase in situ. The kinase an S6 in in is inhibited by to p70 is p70 p70 in vitro as the p70 that p70 the mTOR the by The mTOR which is in to is also to protect p70 against to and protection against p70 kinase The ability mTOR to protect p70 mTOR which mTOR in vitro also the ability mTOR to p70 the mTOR which is in vitro is and is to bind in vitro protection for p70 against in situ. the in to mTOR also an mTOR for p70 S6 p70 S6 kinase protect eIF-4E BP1 rapamycin-induced BP1 and p70 the by the to The and the to and by S6 The kinase by and to The to The for and and the proteins by p70 kinase by mTOR to in and as as in each to S6 kinase each is the kinase The each to and and to p70 and the mTOR eIF-4E in as to that for to the eIF-4E BP1 to phosphorylation the eIF-4E BP1 in the the eIF-4E BP1 to the p70 to eIF-4E BP1 mTOR the rapamycin-induced in eIF-4E BP1 and mTOR and and mTOR the ability mTOR to protect against is by the mTOR through an eIF-4E BP1 phosphorylation by and the phosphorylation eIF-4E BP1 by and rapamycin. BP1 the as and and and the to and mTOR rapamycin-induced eIF-4E BP1 and the each the each and and in the for for and for and the to the by and the proteins by The for and for The proteins in the by to and The each and to and to the mTOR mTOR eIF-4E BP1 rapamycin-induced an mTOR kinase to in BP1 and as in each to as to to the by for and the for and and the proteins by and by The to and to the mTOR in p70 S6 kinase and in to and mTOR mutants to both mTOR by to the by the p70 kinase can by p70 that have to that is to situ by rapamycin. p70 the p70 in p70 that kinase that is that p70 both in the is to by p70 can protect eIF-4E BP1 rapamycin-induced dephosphorylation, p70 the The eIF-4E BP1 and the the p70 and rapamycin. the p70 p70 S6 as as in the eIF-4E the the inhibited by rapamycin. the in the in the eIF-4E that p70 is eIF-4E BP1 phosphorylation in situ. The mTOR an and and the the and by the The the for to the vitro phosphorylation that the vitro mTOR by in the mTOR to in to to the kinase The mTOR which is to mTOR to the in which to the which to mTOR vitro that the mTOR is and is that the an ability to phosphorylation in an to an which kinase The ability to in in vitro to is is mTOR to in vitro in Previous work has the in and and that in can the mTOR to We that mTOR by in the mTOR to in mTOR mTOR to The also to the complex to an to as the mTOR to is to the mTOR in situ by ability to the p70 kinase in situ. The kinase an S6 in in is inhibited by to p70 is p70 p70 in vitro as the p70 that p70 the mTOR the by The mTOR which is in to is also to protect p70 against to and protection against p70 kinase The ability mTOR to protect p70 mTOR which mTOR in vitro also the ability mTOR to p70 the mTOR which is in vitro is and is to bind in vitro protection for p70 against in situ. the in to mTOR also an mTOR for p70 S6 eIF-4E in as to that for to the eIF-4E BP1 to phosphorylation the eIF-4E BP1 in the the eIF-4E BP1 to the p70 to eIF-4E BP1 mTOR the rapamycin-induced in eIF-4E BP1 and mTOR and and mTOR the ability mTOR to protect against is by the mTOR through an The in p70 S6 kinase and in to and mTOR mutants to both mTOR by to the by the p70 kinase can by p70 that have to that is to situ by rapamycin. p70 the p70 in p70 that kinase that is that p70 both in the is to by p70 can protect eIF-4E BP1 rapamycin-induced dephosphorylation, p70 the The eIF-4E BP1 and the the p70 and rapamycin. the p70 p70 S6 as as in the eIF-4E the the inhibited by rapamycin. the in the in the eIF-4E that p70 is eIF-4E BP1 phosphorylation in situ. the the ability mTOR to in vitro to phosphorylation can the ability mTOR to bind in in and the mTOR in vitro that the mTOR which is to bind in partially protect the p70 S6 kinase by the p70 S6 and protection an mTOR to eIF-4E show that the rapamycin-induced eIF-4E BP1, that can also by mTOR mTOR as p70 S6 the the phosphorylation eIF-4E BP1 is that eIF-4E BP1 p70 is to rapamycin-induced eIF-4E BP1, that the rapamycin-induced in phosphorylation eIF-4E is the the mTOR is eIF-4E BP1 as as the p70 S6 p70 is eIF-4E is to that the phosphorylation both p70 and eIF-4E BP1, each p70 eIF-4E in and that the ability mTOR to protect both p70 and eIF-4E BP1 rapamycin-induced in situ is by mTOR that mTOR that the mTOR and which also the in vitro mTOR mTOR protection p70 that the rapamycin·FKBP12 complex in vitro mTOR is that an mTOR is to the phosphorylation the p70 kinase and eIF-4E BP1 in and the rapamycin·FKBP12 to the by which mTOR to the phosphorylation p70 and eIF-4E have ability mTOR mTOR to to p70 S6 kinase eIF-4E BP1 to mTOR p70 and eIF-4E BP1 the that mTOR the phosphorylation proteins can is that mTOR acts BP1 by protein protein that p70 and eIF-4E that mTOR BP1 is the the that p70 in situ phosphorylation that can inhibited by that is by rapamycin. mTOR to the that p70 to the an eIF-4E by the mTOR The the kinase that mTOR is have kinase in in is kinase is an the mTOR an BP1, the mTOR the mTOR p70 to the in that to rapamycin-induced the mTOR to the in the also that the to to the the We that mTOR mTOR p70 rapamycin-induced The mTOR in p70 in p70 is mTOR by the in that mTOR some protection p70 by the protection is that by mTOR which p70 the mTOR the by to p70 to to the p70 in the mTOR to that in the for the mTOR is is that mTOR is to in ability to to the p70 S6 is to the by mTOR to to mTOR mTOR for and is to mTOR and as mTOR the mTOR is also p70 S6 kinase and an eIF-4E BP1 phosphorylation the mTOR the to for the the mTOR to p70 and eIF-4E The proteins that and the and that p70 and eIF-4E BP1 the the in and that and mTOR can the phosphorylation in vitro have The the the ability mTOR to in vitro to phosphorylation can the ability mTOR to bind in in and the mTOR in vitro that the mTOR which is to bind in partially protect the p70 S6 kinase by the p70 S6 and protection an mTOR The to eIF-4E show that the rapamycin-induced eIF-4E BP1, that can also by mTOR mTOR as p70 S6 the the phosphorylation eIF-4E BP1 is that eIF-4E BP1 p70 is to rapamycin-induced eIF-4E BP1, that the rapamycin-induced in phosphorylation eIF-4E is the the mTOR is eIF-4E BP1 as as the p70 S6 p70 is eIF-4E is to that the phosphorylation both p70 and eIF-4E BP1, each p70 eIF-4E The in and that the ability mTOR to protect both p70 and eIF-4E BP1 rapamycin-induced in situ is by mTOR that mTOR that the mTOR and which also the in vitro mTOR mTOR protection p70 that the rapamycin·FKBP12 complex in vitro mTOR is that an mTOR is to the phosphorylation the p70 kinase and eIF-4E BP1 in and the rapamycin·FKBP12 to the by which mTOR to the phosphorylation p70 and eIF-4E have ability mTOR mTOR to to p70 S6 kinase eIF-4E BP1 to mTOR p70 and eIF-4E BP1 the that mTOR the phosphorylation proteins can is that mTOR acts BP1 by protein protein that p70 and eIF-4E that mTOR BP1 is the the that p70 in situ phosphorylation that can inhibited by that is by rapamycin. mTOR to the that p70 to the an eIF-4E by the mTOR The the kinase that mTOR is have kinase in in is kinase is an the mTOR an BP1, the mTOR The the mTOR p70 to the in that to rapamycin-induced the mTOR to the in the also that the to to the the We that mTOR mTOR p70 rapamycin-induced The mTOR in p70 in p70 is mTOR by the in that mTOR some protection p70 by the protection is that by mTOR which p70 the mTOR the by to p70 to to the p70 in the mTOR to that in the The for the mTOR is is that mTOR is to in ability to to the p70 S6 is to the by mTOR to to mTOR mTOR for and is to mTOR and as mTOR the mTOR is also p70 S6 kinase and an eIF-4E BP1 phosphorylation the mTOR the to for the the mTOR to p70 and eIF-4E The proteins that and the and that p70 and eIF-4E BP1 the the in and that and mTOR can the phosphorylation in vitro have in and that and mTOR can the phosphorylation in vitro have in and that and mTOR can the phosphorylation in vitro have and that and mTOR can the phosphorylation in vitro have
Hara et al. (Wed,) studied this question.